Research Overview of Dutasteride
Veltride 0.5 mg is a pharmaceutical formulation containing dutasteride, a dual 5-alpha reductase inhibitor manufactured by Intas Pharmaceuticals. Dutasteride is a synthetic 4-azasteroid compound that demonstrates inhibitory activity against both type I and type II 5-alpha reductase enzymes in preclinical models. Researchers at Stroid UK Shop can examine this compound’s mechanism of action in blocking the conversion of testosterone to dihydrotestosterone (DHT) across various tissue types. The pharmaceutical-grade preparation ensures consistent analytical standards for laboratory investigations studying androgen metabolism pathways.
Laboratory Research Applications
Research scientists investigate dutasteride in models of benign prostatic hyperplasia and androgenetic alopecia to understand DHT-mediated tissue responses. The compound’s dual enzyme inhibition profile makes it valuable for comparative studies with other 5-alpha reductase inhibitors available in our general health research compounds category. Laboratory protocols examine dutasteride’s effects on prostatic tissue morphology, hair follicle cycling, and sebaceous gland activity in controlled experimental conditions. Academic institutions analyse the compound’s pharmacokinetic properties, including its extended half-life and tissue distribution patterns. Research applications extend to studies investigating hormonal signalling cascades and androgen receptor interactions. Scientists may also examine dutasteride in combination with other research compounds from our SARMs collection to study selective androgen modulation mechanisms.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Dutasteride |
| Dosage Form | 0.5 mg oral capsules |
| Manufacturer | Intas Pharmaceuticals |
| CAS Registry | 164656-23-9 |
| Molecular Formula | C₂₇H₃₀F₆N₂O₂ |
| Molecular Weight | 528.53 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | 5α-reductase inhibition studies |
Research Compliance Information
Veltride 0.5 mg is supplied exclusively for in-vitro research purposes and is not intended for human consumption or clinical applications. Researchers investigating androgen metabolism may also examine complementary compounds from our peptides research category for comprehensive hormonal pathway studies. Laboratory personnel must handle this compound according to standard research protocols and maintain appropriate documentation for regulatory compliance. This product is restricted to qualified research institutions and licensed laboratories conducting legitimate scientific investigations.
